$6.43
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Rockwell Medical Advances Quality and Regulatory Leadership
Rockwell Medical Regains Compliance With Nasdaq Minimum Bid Price Requirement
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
Overview
52-week range
$0.64
$2.10
100% of range
Avg surprise (last 3)
-111.1%
Avg reaction (last 2)
-5.4%
0% positive
Latest IV / EM
1045%
EM ±174.5% · $5 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.04 | $-0.01 | -300.0% | 0.0% | -3.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.05 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.05 | $-0.05 | 0.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.04 | $-0.03 | -33.3% | — | -7.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.04 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.01 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.06 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.18 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | BMO | -$0.17 | -$0.50 | +66.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | — | $16M | $16M | $19M | — | $28M | $26M |
| Cost of revenue | $14M | — | $14M | $14M | $16M | — | $22M | $21M |
| Gross profit | $3M | — | $2M | $3M | $3M | — | $6M | $5M |
| Operating income | $-1M | — | $-2M | $-1M | $-1M | — | $2M | $515,000 |
| Net income | $-2M | — | $-2M | $-1M | $-2M | — | $2M | $343,000 |
| EPS (diluted) | $-0.04 | — | $-0.05 | $-0.05 | $-0.04 | — | $0.04 | $0.01 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | $11M | $14M | $12M | $11M | $16M | $12M | $12M |
| Inventory | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $6M |
| Total current assets | $37M | $38M | $38M | $32M | $33M | $37M | $34M | $30M |
| Total assets | $57M | $57M | $57M | $53M | $54M | $59M | $57M | $53M |
| Long-term debt | $8M | $9M | $9M | $9M | $9M | $8M | $8M | $8M |
| Total liabilities | $22M | $20M | $20M | $22M | $22M | $27M | $28M | $30M |
| Total equity | $36M | $37M | $37M | $30M | $32M | $33M | $29M | $23M |